Search Videos and More
Course
Virtual Medicine: Best Practices in Medical Extended Reality
Thursday, March 30, 2023, 9:00 AM - Friday, March 31, 2023, 3:45 PM Sofitel Los Angeles at Beverly Hills, 8555 Beverly Boulevard, Los Angeles, CA
News
Adrenaline Research Offers Insight Into Pre-Diagnostic and Non-Motor Symptoms of Parkinson’s Disease
After nearly 150 years of failed therapies for Parkinson’s disease, the introduction of dopamine for patient treatment began in the late 1960s, and its transformative effect on patient movement, function and speech was immediately embraced. Since that time, dopamine-based therapies have formed the backbone of Parkinson’s therapy and have informed the basis of scientific understanding regarding the cause of this common neurodegenerative condition.
News
Metrics - 2023 Neuro Annual Report
Metrics featured in the 2023 Neurosciences Annual Report
News
2022 Academic Highlights
An experimental vaccine created by scientists at Cedars-Sinai showed preliminary evidence of generating an immune response in some patients against glioblastoma. The results were published in Clinical Cancer Research.
News
Attacking Parkinson’s Before It Begins
A growing number of researchers and clinicians believe the key to addressing the cause of Parkinson’s—and identifying a cure—may be found in studying the nonmotor symptoms that occur before neurological symptoms of Parkinson’s emerge.
News
Stem Cells for ALS, From Lower to Upper Motor Neurons
After promising findings in a safety trial for patients with ALS focusing on stem cell injections in lower motor neurons, researchers are now studying the investigative therapy in the motor cortex.
News
Turning Complex Procedures Into Learning Opportunities
When patients undergo procedures such as deep-brain stimulation for Parkinson’s or implantation of temporary electrodes for epilepsy diagnostics, scientists from an internationally recognized leading research group in human cognitive neurophysiology are at the bedside—investigating the mechanisms of learning, memory and decision-making at the single-neuron and network level—and driving the science forward.
News
The Human Side of Artificial Intelligence
Cedars-Sinai spine surgeons, in collaboration with the Department of Computational Biomedicine, have made exciting progress in their machine-learning algorithms to predict post-surgical pain duration, medication dependency, readmission rates and other key outcomes in spine surgery.
News
An Expanded View Into Multiple Sclerosis and Alzheimer’s Disease
Cutting-edge imaging techniques have the potential to revolutionize diagnosis, disease prediction and progression tracking for a wealth of neurological conditions, including multiple sclerosis (MS), Parkinson’s disease and Alzheimer’s disease.
News
The Human Side of AI: Predicting Spine Surgery Outcomes
Cedars-Sinai Department of Computational Biomedicine Develops Artificial Intelligence Tools to Help Spine Surgeons Predict Patient Outcomes and Address Medication Issues Before They Arise
News
New Research Detects Potential Hidden Cause of Dementia
A Cedars-Sinai Study Suggests Physicians Treating Dementia Should Look for Cerebrospinal Fluid Leak—A Treatable Cause of an Otherwise Incurable Condition
News
What to Know About the Recently Approved Alzheimer’s Drug
Leqembi, Newly Approved by FDA, Shows Potential Benefit for Patients With Early-Stage Disease, But Availability Will Take Time, Says Cedars-Sinai Expert
BROADCASTMED